Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pancreatic Neoplasms 3Glioblastoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Oligodendroglioma 1Glioma 1Childhood Brain Neoplasm 1Carcinoma, Basal Cell 1Breast Neoplasms 1Astrocytoma 1Acidemia, isovaleric 1

Interventions

Itraconazole 3Biopsy 2arsenous acid 1X-Rays 1Surgical Procedures, Operative 1Sunscreening Agents 1Nivolumab 1Niacinamide 1Mohs Surgery 1HhAntag691 1Ascorbic Acid 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Basal Cell × Surgical Procedures, Operative × Clear all
NCT07144384 2026-02-13

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
40 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡